Technische Universität Dresden
Clinical trials sponsored by Technische Universität Dresden, explained in plain language.
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase: PHASE3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lung surgery ventilation showdown: high vs low pressure in 2,200 patients
Knowledge-focused CompletedThis study looked at 2,200 adults having lung surgery where one lung is deflated during the procedure. Doctors tested two ways of using the breathing machine: one with higher pressure and periodic deep breaths, the other with lower pressure and no deep breaths. The goal was to se…
Phase: NA • Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC